121 related articles for article (PubMed ID: 20566769)
1. Oligochlorophens are potent inhibitors of Bacillus anthracis.
Foss MH; Weibel DB
Antimicrob Agents Chemother; 2010 Sep; 54(9):3988-90. PubMed ID: 20566769
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
3. New inhibitors of colony spreading in Bacillus subtilis and Bacillus anthracis.
Hao X; Nguyen T; Kearns DB; Arpin CC; Fall R; Sammakia T
Bioorg Med Chem Lett; 2011 Sep; 21(18):5583-8. PubMed ID: 21784632
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.
Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M
Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Bacillus anthracis and potential surrogate bacilli growth from spore inocula by nisin and other antimicrobial peptides.
Montville TJ; De Siano T; Nock A; Padhi S; Wade D
J Food Prot; 2006 Oct; 69(10):2529-33. PubMed ID: 17066940
[TBL] [Abstract][Full Text] [Related]
7. [Methodic approaches to testing Bacillus anthracis susceptibility to antibacterials].
Buravtseva NP; Aksenova LIu; Riazanova AG
Antibiot Khimioter; 2009; 54(3-4):6-10. PubMed ID: 19711841
[TBL] [Abstract][Full Text] [Related]
8. Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK).
Shapiro JA; Varga JJ; Parsonage D; Walton W; Redinbo MR; Ross LJ; White EL; Bostwick R; Wuest WM; Claiborne A; Goldberg JB
ChemMedChem; 2019 Jan; 14(1):78-82. PubMed ID: 30376607
[TBL] [Abstract][Full Text] [Related]
9. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
[TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
11. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.
Jang KH; Nam SJ; Locke JB; Kauffman CA; Beatty DS; Paul LA; Fenical W
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7822-4. PubMed ID: 23776159
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.
Mo S; Krunic A; Chlipala G; Orjala J
J Nat Prod; 2009 May; 72(5):894-9. PubMed ID: 19371071
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.
Tipparaju SK; Joyasawal S; Forrester S; Mulhearn DC; Pegan S; Johnson ME; Mesecar AD; Kozikowski AP
Bioorg Med Chem Lett; 2008 Jun; 18(12):3565-9. PubMed ID: 18499454
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.
Cavallo JD; Ramisse F; Girardet M; Vaissaire J; Mock M; Hernandez E
Antimicrob Agents Chemother; 2002 Jul; 46(7):2307-9. PubMed ID: 12069996
[TBL] [Abstract][Full Text] [Related]
15. Common garlic (Allium sativum L.) has potent Anti-Bacillus anthracis activity.
Kaur R; Tiwari A; Manish M; Maurya IK; Bhatnagar R; Singh S
J Ethnopharmacol; 2021 Jan; 264():113230. PubMed ID: 32853741
[TBL] [Abstract][Full Text] [Related]
16. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
[TBL] [Abstract][Full Text] [Related]
17. Tetrazole-Based
Alumasa JN; Goralski TDP; Keiler KC
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760903
[No Abstract] [Full Text] [Related]
18. Selection of Bacillus anthracis isolates resistant to antibiotics.
Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Bacillus anthracis in an endemic area.
Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M
Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
Caplan DM; Ivana S; Caplan ME
Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
